1. Home
  2. IVA vs XPOF Comparison

IVA vs XPOF Comparison

Compare IVA & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • XPOF
  • Stock Information
  • Founded
  • IVA 2011
  • XPOF 2017
  • Country
  • IVA France
  • XPOF United States
  • Employees
  • IVA N/A
  • XPOF N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • XPOF Services-Misc. Amusement & Recreation
  • Sector
  • IVA Health Care
  • XPOF Consumer Discretionary
  • Exchange
  • IVA Nasdaq
  • XPOF Nasdaq
  • Market Cap
  • IVA 359.6M
  • XPOF 295.1M
  • IPO Year
  • IVA 2020
  • XPOF 2021
  • Fundamental
  • Price
  • IVA $3.62
  • XPOF $9.13
  • Analyst Decision
  • IVA Strong Buy
  • XPOF Buy
  • Analyst Count
  • IVA 4
  • XPOF 9
  • Target Price
  • IVA $10.50
  • XPOF $13.94
  • AVG Volume (30 Days)
  • IVA 22.8K
  • XPOF 793.7K
  • Earning Date
  • IVA 03-26-2025
  • XPOF 07-31-2025
  • Dividend Yield
  • IVA N/A
  • XPOF N/A
  • EPS Growth
  • IVA N/A
  • XPOF N/A
  • EPS
  • IVA N/A
  • XPOF N/A
  • Revenue
  • IVA $14,591,573.00
  • XPOF $317,536,000.00
  • Revenue This Year
  • IVA $15.38
  • XPOF $1.58
  • Revenue Next Year
  • IVA $24.22
  • XPOF $6.40
  • P/E Ratio
  • IVA N/A
  • XPOF N/A
  • Revenue Growth
  • IVA N/A
  • XPOF N/A
  • 52 Week Low
  • IVA $1.53
  • XPOF $6.64
  • 52 Week High
  • IVA $4.05
  • XPOF $18.95
  • Technical
  • Relative Strength Index (RSI)
  • IVA 58.88
  • XPOF 54.06
  • Support Level
  • IVA $3.13
  • XPOF $8.84
  • Resistance Level
  • IVA $3.54
  • XPOF $9.38
  • Average True Range (ATR)
  • IVA 0.27
  • XPOF 0.55
  • MACD
  • IVA 0.02
  • XPOF 0.05
  • Stochastic Oscillator
  • IVA 69.66
  • XPOF 66.09

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.

Share on Social Networks: